Dyne Therapeutics
205 hedge funds and large institutions have $1.97B invested in Dyne Therapeutics in 2025 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 110 increasing their positions, 38 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
5% more funds holding
Funds holding: 196 → 205 (+9)
3.61% less ownership
Funds ownership: 113.15% → 109.54% (-3.6%)
24% less call options, than puts
Call options by funds: $2.45M | Put options by funds: $3.22M
Holders
205
Holding in Top 10
7
Calls
$2.45M
Puts
$3.22M
Top Buyers
| 1 | +$67.1M | |
| 2 | +$32.5M | |
| 3 | +$31.2M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$26.7M |
| 5 |
VPC
Vestal Point Capital
New York
|
+$25.9M |
Top Sellers
| 1 | -$92.5M | |
| 2 | -$21.6M | |
| 3 | -$12.5M | |
| 4 |
B
Braidwell
Stamford,
Connecticut
|
-$6.87M |
| 5 |
D.E. Shaw & Co
New York
|
-$5.91M |
